The Effect of a Prasugrel- versus a Ticagrelor-based Strategy on Total Ischemic and Bleeding Events in Patients with Acute Coronary Syndromes.
Alp AytekinJohn Joseph CoughlanGjin NdrepepaSalvatore CasseseShqipdona LahuSebastian KufnerKatharina MayerErion XhepaSenta GewaltMichael JonerAlexander HapfelmeierDominick J AngiolilloMaurizio MenichelliGert RichardtFranz Josef NeumannHeribert SchunkertAdnan KastratiPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
A prasugrel based strategy was associated with a reduction in total MI events in comparison to a ticagrelor based strategy in patients with ACS undergoing invasive assessment. Total BARC type 3 to 5 bleeding events were comparable between the two groups. Given the importance of this topic, future studies to confirm these findings would be welcome.